Inferior Survival with Use of Autologous Stem Cell Transplant As Second-Line Therapy in Multiple Myeloma

Category Primary study
JournalBlood
Year 2019
This article has no abstract
Epistemonikos ID: 47bd3962641f2125b5a570edb0989951576274f7
First added on: Feb 11, 2025